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Pat. with
bioabsorbable
polymer DES
n = 13
Pat. with durable
polymer DES
n = 37
Total
n = 50
Age at 1y FUP 56,4
(IQR: 51,5 - 60,0)
61,6
(IQR: 54,2 - 70,0)
60,2
(IQR: 53,0 - 66,0)
Gender (m/f) 10 / 3 29 / 8 39 / 11
FUP period 364,2 (17,3) 363,3 (18,4) 363,5 (18,0)
DES (EES/ZES/
BES)
n ¼ 17 (-/-/17) n ¼ 43 (25/18/-) n ¼ 60
Stent length 22,94 (7,25) 23,3 (8,07) 23,2 (7,79)
Stent diameter 2,99 (0,38) 2,97 (0,4) 2,97 (0,39)
Struts total 1y* 3.291
(193,6 80,1)
12.385
(288 168,9)
15.676
(261,3 154,6)
DES with LASM 0 10 10
DES without LASM 17 33 50
Patients and stents characteristics, signiﬁcant difference between groups at occurance of
LASM (p¼0,0492)
* struts counted in every 4th frame
Stent Failure
(N=11)
Non-Stent Failure
(N=27) p value
Baseline
characteristics
Age, years 652 622 0.22
Male, % (n) 91 (10) 100 (27) 0.30
Diabetes, % (n) 55 (6) 59 (16) 0.79
Acute coronary
syndrome, % (n)
45 (5) 41 (11) 0.79
NIRS ﬁndings
before stenting
LCBI in the
stented segment
160112 9870 0.042
MaxLCBI4mm * 503335 353242 0.12
LCBI in the
proximal reference
5981 5279 0.83
LCBI in the distal
reference
4557 2784 0.55
MaxLCBI4mm
<100, % (n)
0 (0) 19 (5) 0.30
Final QCA results
at index procedure
Total stent
length, mm
30.522.0 32.015.1 0.83
Minimal lumen
diameter, mm
2.20.5 2.20.4 0.94
Reference vessel
diameter, mm
2.80.3 3.00.3 0.22
Percent
diameter stenosis,
%
23.811.2 20.311.4 0.38
* MaxLCBI4mm ¼ maximum LCBI in any 4mm-long segment
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SConclusions: Pre-intervention NIRS revealed more LRP in lesions that subsequently
developed DES failure compared to DES-treated lesions without stent failure. Pre-
intervention NIRS evaluation may help to identify lesions at high risk of DES
thrombosis or restenosis.
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Background: Uncovered stent struts of drug-eluting stents (DES) are associated with
late stent thrombosis. Early and late malapposition of stent struts may be the major
mechanisms for uncovered struts. Durable polymer may contribute to late acquired
stent malapposition. Optical coherence tomography (OCT) enables the evaluation of
stent strut apossition due to high-resoluted intravascular images.
Methods: This study examines malapposition of DES with and without bioabsorbable
polymer in patients who underwent elective percutaneous coronary intervention (PCI).
Methods: Fifty patients treated with 60 DESs (25 Everolimus-eluting stents [EES], 18
Zotarolimus- eluting stents [ZES], 17 Biolimus-eluting stents [BES]) underwent OCT
directly after implantation and after 12 months.
Results: Postintervention acute stent malapposition (ASM) occurred in 30 stents
(50%). Of these, malappositions in 21 stents resolved completely (70%), whereas 9
malappositions persisted after one year (30%, malapposed segements in 6 stents
resolved partly whereas malappositions in 3 stents persisted completely). At this time-
point, a total 15 stents (25%) with late stent malappositions were detected due to late
acquired stent malapposition (LASM) in 10 stents (17%). The occurance of LASM
was signiﬁcantly higher in stents without bioabsorbable polymer (10 in EES and ZES
- 100%) than in stents with bioabsorbable polymer (0 BES - 0%; p¼0,0492).
Conclusions: The use of bioabsorbable polymer may reduce late acquired stent
malapposition.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-585
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Background: Due to the lack of imaging modalities with a resolution down to the
magnitude of a few cells, the direct inﬂuence of endothelial progenitor cells (EPC) on
re-endothelialization of drug-eluting stents has not been established in patients. Here,
we assessed the potential of different subsets of circulating endothelial cells and EPC
to inﬂuence stent re-endothelialization using second generation optical coherence
tomography (OCT).
Methods: In 40 patients, everolimus-eluting stents were assessed by optical frequency
density intensity OCT 5-7 months after stent implantation. Stent strut coverage as well
as neointima formation was derived from detailed analysis of OCT data. Circulating
endothelial cells (CEC; CD31+CD45-) and different subsets of EPC (e.g.
CD34+KDR+, CD34+KDR+CD45dim, CD3+CD31+, CD133+) were analyzed by
ﬂow cytometry. Statistical analysis was performed by mixed linear effect models
integrating OCT and ﬂow cytometry data as well as multiple clinical variables.
Results: Stent strut coverage and frequency of different cell populations were highly
comparable with previous OCT and ﬂow cytometry data. On univariate and in mixed
linear effect models, no association between EPC counts and re-endothelialization was
detected. For CD31+CD45- counts, an inverse relationship with re-endothelialization
was identiﬁed by mixed linear effect model building adjusting for age, female sex,
diabetes mellitus, NYHA and CCS stadium, serum triglycerides, glucose and creati-
nine (beta ¼ -8.375, p¼0.011).
Conclusions: Circulating CEC were associated with low stent strut coverage. There
was no signiﬁcant association between circulating EPC and healing after drug-eluting
stent implantation. These data suggest that endothelial damage quantitated by CEC
may represent a more important mediator of late stent re-endothelialization than
endovascular repair assessed by EPC.acts/POSTER/Intravascular Imaging and PCI B177
